Mga Batayang Estadistika
| CIK | 1595262 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to IMS Health Holdings, Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| October 13, 2016 |
15-12B 1 d271953d1512b.htm 15-12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 001-36381 IMS HEALTH HOLDINGS, INC. (Exact |
|
| October 3, 2016 |
EX-99.25 2 ruleprovisionnotice.htm NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES The New York Stock Exchange hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on October 14, 2016, pursuant to the provisions of Rule 12d2-2 (a). [ X ] 17 CFR 240.12d |
|
| October 3, 2016 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) October 3, 2016 IMS Health Holdings, Inc. (Exact name of registrant as specified in charter) Delaware 001-36381 27-1335689 (State or other jurisdiction of incorporation) (Comm |
|
| October 3, 2016 |
EX-99.1 Exhibit 99.1 Contacts: Tor Constantino QuintilesIMS Media Relations [email protected] +1.484.567.6732 (office / mobile) Tom Kinsley QuintilesIMS Investor Relations [email protected] +1.203.448.4691 News For Immediate Release Phil Bridges QuintilesIMS Media Relations [email protected] +1.919.998.1653 (office) +1.919.457.6347 (mobile) Todd Kasper Quintil |
|
| October 3, 2016 |
POSASR As filed with the Securities and Exchange Commission on October 3, 2016 Registration No. |
|
| October 3, 2016 |
S-8 POS 1 d269992ds8pos.htm S-8 POS As filed with the Securities and Exchange Commission on October 3, 2016 Registration No. 333-195143 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Post-Effective Amendment No. 1 to FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 IMS HEALTH HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 27- |
|
| September 28, 2016 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) September 28, 2016 IMS Health Holdings, Inc. (Exact name of registrant as specified in charter) Delaware 001-36381 27-1335689 (State or other jurisdiction of incorporation) (Commis |
|
| September 22, 2016 |
Other Events, Submission of Matters to a Vote of Security Holders 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) September 22, 2016 IMS Health Holdings, Inc. (Exact name of registrant as specified in charter) Delaware 001-36381 27-1335689 (State or other jurisdiction of incorporation) (Commis |
|
| September 14, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| September 14, 2016 |
Exhibit 99.1 IMS Health Announces Pricing on Upsized Offering of Senior Notes In Connection with Quintiles IMS Merger DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.-(BUSINESS WIRE)-September 14, 2016-IMS Health Holdings, Inc. (NYSE:IMS) today announced the pricing of its offering of $1.75 billion equivalent in gross proceeds of senior notes, consisting of $1.05 billion of U.S. Dollar notes and ?625 |
|
| September 14, 2016 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events 8-K 1 a51419938.htm IMS HEALTH HOLDINGS, INC. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) September 14, 2016 IMS Health Holdings, Inc. (Exact name of registrant as specified in charter) Delaware 001-36381 27-1335689 (State o |
|
| September 12, 2016 |
DEFA14A 1 d251868ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as |
|
| September 12, 2016 |
IMS Health Announces Offering of Senior Notes In Connection with Quintiles IMS Merger Exhibit 99.1 IMS Health Announces Offering of Senior Notes In Connection with Quintiles IMS Merger DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.-(BUSINESS WIRE)-September 12, 2016-IMS Health Holdings, Inc. (NYSE:IMS) today announced that its wholly owned subsidiary, IMS Health Incorporated, intends to raise $1.5 billion equivalent in gross proceeds through an offering of senior notes. The company |
|
| September 12, 2016 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) September 12, 2016 IMS Health Holdings, Inc. (Exact name of registrant as specified in charter) Delaware 001-36381 27-1335689 (State or Other Jurisdiction of Incorporation) (Commission |
|
| August 29, 2016 |
DEFA14A 1 d248242ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as |
|
| August 17, 2016 |
DEFM14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| July 28, 2016 |
IMS Health Holdings 10-Q (Quarterly Report) 10-Q 1 ims-10q20160630.htm 10-Q ‘ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission |
|
| July 28, 2016 |
EX-10.2 3 ims-ex102371.htm EX-10.2 Exhibit 10.2 FIRST AMENDMENT TO THE IMS HEALTH INCORPORATED EMPLOYEE PROTECTION PLAN (as amended and restated effective January 1, 2014) Effective as of the date written below, the IMS Health Incorporated Employee Protection Plan (the “Plan”), as amended and restated effective January 1, 2014 is amended as follows: The definition of “Change in Control” is amended |
|
| July 28, 2016 |
Fourth Amendment to the IMS Health Incorporated Retirement Excess Plan (effective May 3, EX-10.3 4 ims-ex103370.htm EX-10.3 Exhibit 10.3 Fourth Amendment to the IMS HEALTH INCORPORATED RETIREMENT EXCESS PLAN This AMENDMENT NO. 4, dated as of May 3, 2016 (this “Amendment”), to that certain IMS Health Incorporated Retirement Excess Plan, as amended and restated effective January 1, 2005, as amended on March 17, 2009, December 8, 2009 and April 5, 2011 (the “Plan”). W I T N E S S E T H: |
|
| July 28, 2016 |
EX-10.1 2 ims-ex101372.htm EX-10.1 Exhibit 10.1 IMS Health Incorporated Employee Protection Plan and Summary Plan Description As Amended and Restated Effective January 1, 2014 I. Administrative Information Plan Administration The Employee Benefits Committee (the "Committee"), a committee of management employees of IMS Health Incorporated (the "Corporation"), is named as the Plan Administrator unde |
|
| July 27, 2016 |
IMS Health Holdings 425 (Prospectus) 425 Filed by Quintiles Transnational Holdings Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: IMS Health Holdings, Inc. Commission File No.: 333-211794 The following is an excerpt of a transcript of the July 27, 2016 quarterly earnings conference call of Quintiles Trans |
|
| July 27, 2016 |
IMS Health Reports Second-Quarter 2016 Results and Raises Full-Year Guidance EX-99.1 2 a51389132ex991.htm EXHIBIT 99.1 Exhibit 99.1 IMS Health Reports Second-Quarter 2016 Results and Raises Full-Year Guidance Revenue up 8.1 percent reported, 8.4 percent constant currency GAAP Net Income: $24 million; Adjusted Net Income: $139 million, up 10.7 percent reported and 15.7 percent constant currency GAAP Diluted Earnings per Share: $0.07; Adjusted Diluted Earnings per Share: $0. |
|
| July 27, 2016 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 a51389132.htm IMS HEALTH HOLDINGS, INC. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 July 27, 2016 Date of Report (Date of earliest event reported) IMS Health Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36381 27-1335689 (State or |
|
| July 20, 2016 |
IMS Health Holdings 425 (Prospectus) Filed by Quintiles Transnational Holdings Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: IMS Health Holdings, Inc. Commission File No.: 333-211794 The following is a transcript of a video communication titled ?Together? by Quintiles Transnational Holdings, Inc. (?Quint |
|
| July 20, 2016 |
IMS Health Holdings 425 (Prospectus) Filed by Quintiles Transnational Holdings Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: IMS Health Holdings, Inc. Commission File No.: 333-211794 The following is a transcript of a video communication titled Grow with us by Quintiles Transnational Holdings, Inc. (Q |
|
| July 19, 2016 |
IMS Health Holdings 425 (Prospectus) Confidential - Quintiles and IMS Health Alliance Filed by Quintiles Transnational Holdings Inc. |
|
| June 17, 2016 |
IMS Health Holdings 425 (Prospectus) 425 1 d205898d425.htm 425 Filed by Quintiles Transnational Holdings Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: IMS Health Holdings, Inc. Commission File No.: 333-211794 The following is a communication to employees sent on June 17, 2016 by Tom Pike, Chief Executive |
|
| June 7, 2016 |
IMS Health Holdings 425 (Prospectus) 425 Filed by Quintiles Transnational Holdings Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: IMS Health Holdings, Inc. Commission File No.: 333-211794 The following is a transcript of remarks by officers of Quintiles Transnational Holdings Inc. at the June 7, 2016 Jeff |
|
| June 6, 2016 |
IMS Health Holdings 425 (Prospectus) 425 Filed by Quintiles Transnational Holdings Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: IMS Health Holdings, Inc. Commission File No.: 333-211794 The following presentation is expected to be used by Quintiles Transnational Holdings Inc. at the June 7, 2016 Jefferi |
|
| May 27, 2016 |
IMS Health Holdings 425 (Prospectus) 425 1 d147902d425.htm 425 Filed by Quintiles Transnational Holdings Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: IMS Health Holdings, Inc. Commission File No.: 001-36381 In response to a customer request, Quintiles Transnational Holdings Inc. is providing the followi |
|
| May 25, 2016 |
IMS Health Holdings 425 (Prospectus) Filed by IMS Health Holdings, Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: IMS Health Holdings, Inc. Commission File No.: 001-36381 The following is a transcript of a video communication by Quintiles Transnational Holdings, Inc. (Quintiles) and IMS Health Holdings, |
|
| May 23, 2016 |
IMS Health Holdings 425 (Prospectus) 425 Filed by Quintiles Transnational Holdings Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: IMS Health Holdings, Inc. Commission File No.: 001-36381 The following is a transcript of a video communication by Quintiles Transnational Holdings, Inc. (?Quintiles?) and IMS |
|
| May 18, 2016 |
IMS Health Holdings 425 (Prospectus) Filed by Quintiles Transnational Holdings Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: IMS Health Holdings, Inc. Commission File No.: 001-36381 The following presentation used or expected to be used by Quintiles Transnational Holdings Inc. in meetings with certain in |
|
| May 17, 2016 |
IMS Health Holdings 425 (Prospectus) Filed by Quintiles Transnational Holdings Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: IMS Health Holdings, Inc. Commission File No.: 001-36381 The following presentation used or expected to be used by Quintiles Transnational Holdings Inc. in meetings with certain in |
|
| May 13, 2016 |
Q / Quintiles Transitional Holdings Inc. / IMS Health Holdings, Inc. - SC 13D Activist Investment SC 13D 1 d167043dsc13d.htm SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Quintiles Transnational Holdings Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of class of securities) 74876Y101 (CUSIP Number) Ronald E. Bruehlman Senior Vice President and Chief Financial Officer |
|
| May 13, 2016 |
SEC Correspondence Letter May 13, 2016 Via EDGAR and E-mail Mr. Stephen Krikorian Accounting Branch Chief Office of Information Technologies and Services U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.C. 20549-4561 Re: IMS Health Holdings, Inc. Form 10-K for the year ended December 31, 2015 Filed February 19, 2016 File No. 001-36381 Dear Mr. |
|
| May 13, 2016 |
IMS / IMS Health Holdings, Inc. / Quintiles Transnational Holdings Inc. - SC 13D Activist Investment SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* IMS Health Holdings, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 44970B109 (CUSIP Number) James H. Erlinger III Executive Vice President, General Counsel and Secretary Quintiles Transnational Holding |
|
| May 11, 2016 |
IMS Health Holdings 425 (Prospectus) 425 1 d191727d425.htm 425 Filed by Quintiles Transnational Holdings Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: IMS Health Holdings, Inc. Commission File No.: 001-36381 The following presentation will be used by representatives of Quintiles Transnational Holdings, I |
|
| May 9, 2016 |
IMS Health Holdings 425 (Prospectus) 425 Filed by Quintiles Transnational Holdings Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: IMS Health Holdings, Inc. Commission File No.: 001-36381 The following is the transcript of an interview of Tom Pike, chief executive officer of Quintiles Transnational Holding |
|
| May 7, 2016 |
IMS Health Holdings 425 (Prospectus) Filed by IMS Health Holdings, Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: IMS Health Holdings, Inc. Commission File No.: 001-36381 The following is a transcript of a video of Jon Resnick, VP and GM of Real World Evidence Solutions at IMS Health Holdings, Inc. (IMS |
|
| May 7, 2016 |
IMS Health Holdings 425 (Prospectus) 425 Filed by IMS Health Holdings, Inc. Pursuant to Rule 425 of the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: IMS Health Holdings, Inc. (Commission File No. 001-36381) The following is a transcript of a video of Dr. Nancy Dreyer, MPH, PhD, Global Chief of Scientific Affairs for the Quintiles Trans |
|
| May 7, 2016 |
IMS Health Holdings 425 (Prospectus) 425 Filed by Quintiles Transnational Holdings Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: IMS Health Holdings, Inc. Commission File No.: 001-36381 The following is the transcript for the video presentation by the Global Chief of Scientific Affairs for Real-World and |
|
| May 7, 2016 |
IMS Health Holdings 425 (Prospectus) 425 Filed by Quintiles Transnational Holdings Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: IMS Health Holdings, Inc. Commission File No.: 001-36381 The following is an email sent by Quintiles Transnational Holdings Inc.: The websites referenced below and information |
|
| May 7, 2016 |
IMS Health Holdings 425 (Prospectus) 425 Filed by Quintiles Transnational Holdings Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: IMS Health Holdings, Inc. Commission File No.: 001-36381 The following is the transcript for the video presentation by the VP and GM of Real World Evidence Solutions at IMS Hea |
|
| May 6, 2016 |
IMS Health Holdings 10-Q (Quarterly Report) 10-Q 1 ims-10q20160331.htm 10-Q ‘ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2016 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commissio |
|
| May 6, 2016 |
IMS HEALTH HOLDINGS, INC. 2014 INCENTIVE AND STOCK AWARD PLAN Performance Share Award Agreement Exhibit 10.2 Name of Participant: Ari Bousbib IMS HEALTH HOLDINGS, INC. 2014 INCENTIVE AND STOCK AWARD PLAN Performance Share Award Agreement Pursuant to the IMS Health Holdings, Inc. 2014 Incentive and Stock Award Plan (as amended from time to time, the “Plan”), IMS Health Holdings, Inc. (the “Company”) has granted to the Participant named above, on the grant date listed on Exhibit A attached her |
|
| May 5, 2016 |
Exhibit 99.1 News For Immediate Release Contacts: Tor Constantino Phil Bridges IMS Health Media Relations Quintiles Media Relations +1.484.567.6732 +1.919.998.1653 [email protected] [email protected] Tom Kinsley Todd Kasper IMS Health Investor Relations Quintiles Investor Relations +1.203.448.4691 +1.919.998.2590 [email protected] [email protected] IMS Healt |
|
| May 5, 2016 |
Investor Briefing May 3, 2016 Exhibit 99.2 Cautionary Statements Regarding Forward Looking Statements This communication contains ?forward-looking statements? within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address |
|
| May 5, 2016 |
EX-10.2 4 d135044dex102.htm EX-10.2 Exhibit 10.2 Execution Version VOTING AGREEMENT This VOTING AGREEMENT, dated as of May 3, 2016 (this “Agreement”), among IMS Health Holdings, Inc., a Delaware corporation (“IMS Health”), and the shareholders of Quintiles Transnational Holdings Inc., a North Carolina corporation (“Quintiles”), listed on Schedule A hereto (each, a “Quintiles Shareholder” and, coll |
|
| May 5, 2016 |
EX-10.3 Exhibit 10.3 Execution Version VOTING AGREEMENT This VOTING AGREEMENT, dated as of May 3, 2016 (this “Agreement”), among IMS Health Holdings, Inc., a Delaware corporation (“IMS Health”), and Dennis B. Gillings, CBE (the “Quintiles Shareholder”). RECITALS WHEREAS, concurrently herewith, IMS Health and Quintiles Transnational Holdings Inc., a North Carolina corporation (“Quintiles”), are ent |
|
| May 5, 2016 |
EX-10.1 3 d135044dex101.htm EX-10.1 Exhibit 10.1 Execution Version VOTING AGREEMENT This VOTING AGREEMENT, dated as of May 3, 2016 (this “Agreement”), among IMS Health Holdings, Inc., a Delaware corporation (“IMS Health”), and the shareholders of Quintiles Transnational Holdings Inc., a North Carolina corporation (“Quintiles”), listed on Schedule A hereto (each, a “Quintiles Shareholder” and, coll |
|
| May 5, 2016 |
GOLDMAN SACHS BANK USA 200 West Street New York, New York 10282 EX-10.4 Exhibit 10.4 EXECUTION COPY GOLDMAN SACHS BANK USA 200 West Street New York, New York 10282 JPMORGAN CHASE BANK, N.A. 383 Madison Avenue New York, New York 10179 CONFIDENTIAL May 3, 2016 IMS Health Holdings, Inc. IMS Health Incorporated 83 Wooster Heights Road Danbury, Connecticut 06810 Attention: Jeffrey Ford Project Cooperstown Commitment Letter Ladies and Gentlemen: You have advised Gol |
|
| May 5, 2016 |
GOLDMAN SACHS BANK USA 200 West Street New York, New York 10282 EX-10.4 Exhibit 10.4 EXECUTION COPY GOLDMAN SACHS BANK USA 200 West Street New York, New York 10282 JPMORGAN CHASE BANK, N.A. 383 Madison Avenue New York, New York 10179 CONFIDENTIAL May 3, 2016 IMS Health Holdings, Inc. IMS Health Incorporated 83 Wooster Heights Road Danbury, Connecticut 06810 Attention: Jeffrey Ford Project Cooperstown Commitment Letter Ladies and Gentlemen: You have advised Gol |
|
| May 5, 2016 |
EX-10.2 Exhibit 10.2 Execution Version VOTING AGREEMENT This VOTING AGREEMENT, dated as of May 3, 2016 (this “Agreement”), among IMS Health Holdings, Inc., a Delaware corporation (“IMS Health”), and the shareholders of Quintiles Transnational Holdings Inc., a North Carolina corporation (“Quintiles”), listed on Schedule A hereto (each, a “Quintiles Shareholder” and, collectively, the “Quintiles Sha |
|
| May 5, 2016 |
EX-2.1 Exhibit 2.1 Execution Version AGREEMENT AND PLAN OF MERGER by and between IMS HEALTH HOLDINGS, INC. and QUINTILES TRANSNATIONAL HOLDINGS INC. Dated as of May 3, 2016 TABLE OF CONTENTS ARTICLE I THE MERGER 2 Section 1.1 The Merger 2 Section 1.2 Closing 2 Section 1.3 Effective Time 2 Section 1.4 Effects of the Merger 3 Section 1.5 Charter; Bylaws 3 Section 1.6 Directors and Officers 3 Section |
|
| May 5, 2016 |
EX-2.1 2 d135044dex21.htm EX-2.1 Exhibit 2.1 Execution Version AGREEMENT AND PLAN OF MERGER by and between IMS HEALTH HOLDINGS, INC. and QUINTILES TRANSNATIONAL HOLDINGS INC. Dated as of May 3, 2016 TABLE OF CONTENTS ARTICLE I THE MERGER 2 Section 1.1 The Merger 2 Section 1.2 Closing 2 Section 1.3 Effective Time 2 Section 1.4 Effects of the Merger 3 Section 1.5 Charter; Bylaws 3 Section 1.6 Direct |
|
| May 5, 2016 |
425 1 d135044d8ka.htm FORM 8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 2) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2016 (May 3, 2016) IMS Health Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36381 27-1 |
|
| May 5, 2016 |
EX-10.1 3 d135044dex101.htm EX-10.1 Exhibit 10.1 Execution Version VOTING AGREEMENT This VOTING AGREEMENT, dated as of May 3, 2016 (this “Agreement”), among IMS Health Holdings, Inc., a Delaware corporation (“IMS Health”), and the shareholders of Quintiles Transnational Holdings Inc., a North Carolina corporation (“Quintiles”), listed on Schedule A hereto (each, a “Quintiles Shareholder” and, coll |
|
| May 5, 2016 |
Investor Briefing May 3, 2016 Exhibit 99.2 Cautionary Statements Regarding Forward Looking Statements This communication contains ?forward-looking statements? within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address |
|
| May 5, 2016 |
8-K/A 1 d135044d8ka.htm FORM 8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 2) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2016 (May 3, 2016) IMS Health Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36381 27 |
|
| May 5, 2016 |
Exhibit 99.1 News For Immediate Release Contacts: Tor Constantino Phil Bridges IMS Health Media Relations Quintiles Media Relations +1.484.567.6732 +1.919.998.1653 [email protected] [email protected] Tom Kinsley Todd Kasper IMS Health Investor Relations Quintiles Investor Relations +1.203.448.4691 +1.919.998.2590 [email protected] [email protected] IMS Healt |
|
| May 5, 2016 |
EX-10.3 Exhibit 10.3 Execution Version VOTING AGREEMENT This VOTING AGREEMENT, dated as of May 3, 2016 (this “Agreement”), among IMS Health Holdings, Inc., a Delaware corporation (“IMS Health”), and Dennis B. Gillings, CBE (the “Quintiles Shareholder”). RECITALS WHEREAS, concurrently herewith, IMS Health and Quintiles Transnational Holdings Inc., a North Carolina corporation (“Quintiles”), are ent |
|
| May 4, 2016 |
IMS Health Holdings 425 (Prospectus) 425 1 d191727d425.htm 425 Filed by Quintiles Transnational Holdings Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: IMS Health Holdings, Inc. Commission File No.: 001-36381 The following is the script for the accompanying presentation by the chief executive officer to m |
|
| May 3, 2016 |
IMS Health Holdings 425 (Prospectus) 425 Filed by IMS Health Holdings, Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: IMS Health Holdings, Inc. Commission File No.: 001-36381 The following is a transcript of the IMS Health Holdings Inc. (?IMS Health?) First Quarter 2016 Earnings conference call, held on M |
|
| May 3, 2016 |
IMS Health Holdings 425 (Prospectus) Filed by IMS Health Holdings, Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: IMS Health Holdings, Inc. Commission File No.: 001-36381 The following FAQs were made available to employees of IMS Health Holdings, Inc. (IMS Health) in connection with merger of IMS Health |
|
| May 3, 2016 |
IMS Health Holdings 425 (Prospectus) Filed by IMS Health Holdings, Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: IMS Health Holdings, Inc. Commission File No.: 001-36381 The following letter was sent to customers of IMS Health Holdings Inc. and Quintiles Transnational Holdings Inc.: May 3, 2016 Dear [Ins |
|
| May 3, 2016 |
IMS Health Holdings 425 (Prospectus) 425 Filed by IMS Health Holdings, Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: IMS Health Holdings, Inc. Commission File No.: 001-36381 The following letter was delivered to employees of IMS Health Holdings Inc.: Quintiles IMS Merger of Equals May 3, 2016 Dear Collea |
|
| May 3, 2016 |
IMS Health Holdings 425 (Prospectus) Filed by IMS Health Holdings, Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: IMS Health Holdings, Inc. Commission File No.: 001-36381 The following information was made available to customers of IMS Health Holdings, Inc. (IMS Health) on IMS Healths microsite, in con |
|
| May 3, 2016 |
IMS Health Holdings 425 (Prospectus) Filed by Quintiles Transnational Holdings Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: IMS Health Holdings, Inc. Commission File No.: 001-36381 The following is a transcript of the May 3, 2016 call of Quintiles Transnational Holdings Inc. and IMS Health Holdings, Inc |
|
| May 3, 2016 |
IMS Health Holdings 425 (Prospectus) Filed by IMS Health Holdings, Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: IMS Health Holdings, Inc. Commission File No.: 001-36381 The following is a transcript of the Quintiles Transnational Holdings Inc. (Quintiles) and IMS Health Holdings, Inc. (IMS Health) S |
|
| May 3, 2016 |
IMS Health Holdings 425 (Prospectus) Filed by Quintiles Transnational Holdings Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: IMS Health Holdings, Inc. Commission File No.: 001-36381 The following is a transcript of the May 3, 2016 quarterly earnings call of Quintiles Transnational Holdings Inc.: Cautiona |
|
| May 3, 2016 |
IMS Health Holdings 425 (Prospectus) 425 Filed by Quintiles Transnational Holdings Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: IMS Health Holdings, Inc. Commission File No.: 001-36381 The following FAQs were made available to Quintiles Transnational Holdings Inc. employees: EMPLOYEE FAQs ? Company Info |
|
| May 3, 2016 |
IMS Health Holdings 425 (Prospectus) Filed by Quintiles Transnational Holdings Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: IMS Health Holdings, Inc. Commission File No.: 001-36381 The following talking points were made available to representatives of Quintiles Transnational Holdings, Inc. on May 2, 201 |
|
| May 3, 2016 |
IMS Health Holdings 425 (Prospectus) Filed by Quintiles Transnational Holdings Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: IMS Health Holdings, Inc. Commission File No.: 001-36381 Email Message to investigators and third parties (includes KOLs, local community contacts) Instructions: Copy and paste thi |
|
| May 3, 2016 |
IMS Health Holdings 425 (Prospectus) 425 1 d191727d425.htm 425 Filed by Quintiles Transnational Holdings Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: IMS Health Holdings, Inc. Commission File No.: 001-36381 The following earnings presentation slides were made available to Quintiles Transnational Holding |
|
| May 3, 2016 |
IMS Health Holdings 425 (Prospectus) 425 1 d191727d425.htm 425 Filed by Quintiles Transnational Holdings Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: IMS Health Holdings, Inc. Commission File No.: 001-36381 Quintiles Employee Message PUBLISHED Subject: From Tom Pike: Quintiles and IMS Health announce me |
|
| May 3, 2016 |
IMS Health Holdings 425 (Prospectus) 425 Filed by Quintiles Transnational Holdings Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: IMS Health Holdings, Inc. Commission File No.: 001-36381 The following letter was made available to Quintiles Transnational Holdings Inc. customers: May 3, 2016 Dear [Insert Cl |
|
| May 3, 2016 |
IMS Health Holdings 425 (Prospectus) Filed by Quintiles Transnational Holdings Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: IMS Health Holdings, Inc. Commission File No.: 001-36381 Quintiles 1st Quarter 2016 Results Agreement to merge with IMS Health in all-stock transaction to create Quintiles IMS, a |
|
| May 3, 2016 |
IMS Health Reports First-Quarter 2016 Results Exhibit 99.1 IMS Health Reports First-Quarter 2016 Results Revenue up 25.2 percent at constant currency Adjusted EBITDA up 9.4 percent at constant currency Adjusted Net Income up 6.4 percent at constant currency Adjusted Diluted Earnings per Share was $0.42 reported, up 9.5 percent at constant currency Constant currency guidance reaffirmed, reported guidance raised DANBURY, Conn.-(BUSINESS WIRE)-M |
|
| May 3, 2016 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 May 3, 2016 Date of Report (Date of earliest event reported) IMS Health Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36381 27-1335689 (State or other jurisdiction (Commission File Number) (I.R.S. |
|
| May 3, 2016 |
EX-10.3 Exhibit 10.3 Execution Version VOTING AGREEMENT This VOTING AGREEMENT, dated as of May 3, 2016 (this “Agreement”), among IMS Health Holdings, Inc., a Delaware corporation (“IMS Health”), and Dennis B. Gillings, CBE (the “Quintiles Shareholder”). RECITALS WHEREAS, concurrently herewith, IMS Health and Quintiles Transnational Holdings Inc., a North Carolina corporation (“Quintiles”), are ent |
|
| May 3, 2016 |
EX-10.5 Exhibit 10.5 LOCK-UP LETTER May 3, 2016 Quintiles Transnational Holdings Inc. 4820 Emperor Blvd. Durham, North Carolina 27703 Ladies and Gentlemen: The undersigned understands that, on the date hereof, Quintiles Transnational Holdings Inc. (the “Company”) and IMS Health Holdings, Inc. (“IMS”) intend to enter into an Agreement and Plan of Merger (the “Merger Agreement”), pursuant to which I |
|
| May 3, 2016 |
EX-10.2 Exhibit 10.2 Execution Version VOTING AGREEMENT This VOTING AGREEMENT, dated as of May 3, 2016 (this “Agreement”), among IMS Health Holdings, Inc., a Delaware corporation (“IMS Health”), and the shareholders of Quintiles Transnational Holdings Inc., a North Carolina corporation (“Quintiles”), listed on Schedule A hereto (each, a “Quintiles Shareholder” and, collectively, the “Quintiles Sha |
|
| May 3, 2016 |
EX-10.2 4 d161975dex102.htm EX-10.2 Exhibit 10.2 Execution Version VOTING AGREEMENT This VOTING AGREEMENT, dated as of May 3, 2016 (this “Agreement”), among Quintiles Transnational Holdings Inc., a North Carolina corporation (“Quintiles”), and the shareholders of IMS Health Holdings, Inc., a Delaware corporation (“IMS Health”), listed on Schedule A hereto (each, a “Shareholder” and, collectively, |
|
| May 3, 2016 |
425 1 d135044d8ka.htm FORM 8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2016 IMS Health Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36381 27-1335689 (State |
|
| May 3, 2016 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2016 IMS Health Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36381 27-1335689 (State or other jurisdiction of incorporation) (Com |
|
| May 3, 2016 |
EX-10.2 Exhibit 10.2 Execution Version VOTING AGREEMENT This VOTING AGREEMENT, dated as of May 3, 2016 (this “Agreement”), among IMS Health Holdings, Inc., a Delaware corporation (“IMS Health”), and the shareholders of Quintiles Transnational Holdings Inc., a North Carolina corporation (“Quintiles”), listed on Schedule A hereto (each, a “Quintiles Shareholder” and, collectively, the “Quintiles Sha |
|
| May 3, 2016 |
EX-10.4 6 d161975dex104.htm EX-10.4 Exhibit 10.4 EXECUTION VERSION SHAREHOLDERS AGREEMENT, dated as of May 3, 2016 by and among Quintiles Transnational Holdings Inc. and CERTAIN SHAREHOLDERS TABLE OF CONTENTS ARTICLE I CERTAIN DEFINITIONS 2 1.1 Defined Terms. 2 ARTICLE II CORPORATE GOVERNANCE; TRANSFER RESTRICTIONS 8 2.1 Board of Directors. 8 2.2 Removal. 10 2.3 Vacancies. 10 2.4 Committees of the |
|
| May 3, 2016 |
EX-2.1 Exhibit 2.1 Execution Version AGREEMENT AND PLAN OF MERGER by and between IMS HEALTH HOLDINGS, INC. and QUINTILES TRANSNATIONAL HOLDINGS INC. Dated as of May 3, 2016 TABLE OF CONTENTS ARTICLE I THE MERGER 2 Section 1.1 The Merger 2 Section 1.2 Closing 2 Section 1.3 Effective Time 2 Section 1.4 Effects of the Merger 3 Section 1.5 Charter; Bylaws 3 Section 1.6 Directors and Officers 3 Section |
|
| May 3, 2016 |
EX-99.1 Exhibit 99.1 News For Immediate Release Contacts: Tor Constantino Phil Bridges IMS Health Media Relations Quintiles Media Relations +1.484.567.6732 +1.919.998.1653 [email protected] [email protected] Tom Kinsley Todd Kasper IMS Health Investor Relations Quintiles Investor Relations +1.203.448.4691 +1.919.998.2590 [email protected] [email protected] I |
|
| May 3, 2016 |
Investor Briefing May 3, 2016 Exhibit 99.2 Cautionary Statements Regarding Forward Looking Statements This communication contains ?forward-looking statements? within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address |
|
| May 3, 2016 |
Investor Briefing May 3, 2016 Exhibit 99.2 Cautionary Statements Regarding Forward Looking Statements This communication contains ?forward-looking statements? within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address |
|
| May 3, 2016 |
EX-2.1 2 d135044dex21.htm EX-2.1 Exhibit 2.1 Execution Version AGREEMENT AND PLAN OF MERGER by and between IMS HEALTH HOLDINGS, INC. and QUINTILES TRANSNATIONAL HOLDINGS INC. Dated as of May 3, 2016 TABLE OF CONTENTS ARTICLE I THE MERGER 2 Section 1.1 The Merger 2 Section 1.2 Closing 2 Section 1.3 Effective Time 2 Section 1.4 Effects of the Merger 3 Section 1.5 Charter; Bylaws 3 Section 1.6 Direct |
|
| May 3, 2016 |
Exhibit 99.1 News For Immediate Release Contacts: Tor Constantino Phil Bridges IMS Health Media Relations Quintiles Media Relations +1.484.567.6732 +1.919.998.1653 [email protected] [email protected] Tom Kinsley Todd Kasper IMS Health Investor Relations Quintiles Investor Relations +1.203.448.4691 +1.919.998.2590 [email protected] [email protected] IMS Healt |
|
| May 3, 2016 |
EX-10.2 Exhibit 10.2 Execution Version VOTING AGREEMENT This VOTING AGREEMENT, dated as of May 3, 2016 (this “Agreement”), among IMS Health Holdings, Inc., a Delaware corporation (“IMS Health”), and the shareholders of Quintiles Transnational Holdings Inc., a North Carolina corporation (“Quintiles”), listed on Schedule A hereto (each, a “Quintiles Shareholder” and, collectively, the “Quintiles Sha |
|
| May 3, 2016 |
EX-10.1 Exhibit 10.1 Execution Version VOTING AGREEMENT This VOTING AGREEMENT, dated as of May 3, 2016 (this “Agreement”), among Quintiles Transnational Holdings Inc., a North Carolina corporation (“Quintiles”), and the shareholders of IMS Health Holdings, Inc., a Delaware corporation (“IMS Health”), listed on Schedule A hereto (each, a “Shareholder” and, collectively, the “Shareholders”). RECITAL |
|
| May 3, 2016 |
EX-10.3 Exhibit 10.3 Execution Version VOTING AGREEMENT This VOTING AGREEMENT, dated as of May 3, 2016 (this “Agreement”), among IMS Health Holdings, Inc., a Delaware corporation (“IMS Health”), and Dennis B. Gillings, CBE (the “Quintiles Shareholder”). RECITALS WHEREAS, concurrently herewith, IMS Health and Quintiles Transnational Holdings Inc., a North Carolina corporation (“Quintiles”), are ent |
|
| May 3, 2016 |
EX-10.3 5 d135044dex103.htm EX-10.3 Exhibit 10.3 Execution Version VOTING AGREEMENT This VOTING AGREEMENT, dated as of May 3, 2016 (this “Agreement”), among IMS Health Holdings, Inc., a Delaware corporation (“IMS Health”), and Dennis B. Gillings, CBE (the “Quintiles Shareholder”). RECITALS WHEREAS, concurrently herewith, IMS Health and Quintiles Transnational Holdings Inc., a North Carolina corpor |
|
| May 3, 2016 |
EX-99.2 11 d161975dex992.htm EX-99.2 Investor Briefing May 3, 2016 Exhibit 99.2 Cautionary Statements Regarding Forward Looking Statements This communication contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, for |
|
| May 3, 2016 |
Exhibit 99.1 News For Immediate Release Contacts: Tor Constantino IMS Health Media Relations +1.484.567.6732 [email protected] Tom Kinsley IMS Health Investor Relations +1.203.448.4691 [email protected] Phil Bridges Quintiles Media Relations +1.919.998.1653 [email protected] Todd Kasper Quintiles Investor Relations +1.919.998.2590 [email protected] IMS Healt |
|
| May 3, 2016 |
GOLDMAN SACHS BANK USA 200 West Street New York, New York 10282 EX-10.4 Exhibit 10.4 EXECUTION COPY GOLDMAN SACHS BANK USA 200 West Street New York, New York 10282 JPMORGAN CHASE BANK, N.A. 383 Madison Avenue New York, New York 10179 CONFIDENTIAL May 3, 2016 IMS Health Holdings, Inc. IMS Health Incorporated 83 Wooster Heights Road Danbury, Connecticut 06810 Attention: Jeffrey Ford Project Cooperstown Commitment Letter Ladies and Gentlemen: You have advised Gol |
|
| May 3, 2016 |
8-K/A 1 d135044d8ka.htm FORM 8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2016 IMS Health Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36381 27-1335689 (Stat |
|
| May 3, 2016 |
Investor Briefing May 3, 2016 Exhibit 99.2 Cautionary Statements Regarding Forward Looking Statements This communication contains ?forward-looking statements? within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address |
|
| May 3, 2016 |
LOCK-UP LETTER May 3, 2016 Quintiles Transnational Holdings Inc. 4820 Emperor Blvd. Durham, North Carolina 27703 Ladies and Gentlemen: The undersigned understands that, on the date hereof, Quintiles Transnational Holdings Inc. (the ?Company?), and IMS Health Holdings, Inc. (?IMS?) intend to enter into an Agreement and Plan of Merger (the ?Merger Agreement?), pursuant to which IMS will be merged wi |
|
| May 3, 2016 |
EX-10.1 Exhibit 10.1 Execution Version VOTING AGREEMENT This VOTING AGREEMENT, dated as of May 3, 2016 (this “Agreement”), among IMS Health Holdings, Inc., a Delaware corporation (“IMS Health”), and the shareholders of Quintiles Transnational Holdings Inc., a North Carolina corporation (“Quintiles”), listed on Schedule A hereto (each, a “Quintiles Shareholder” and, collectively, the “Quintiles Sha |
|
| May 3, 2016 |
FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2016 QUINTILES TRANSNATIONAL HOLDINGS INC. (Exact name of registrant as specified in its charter) North Carolina 001-35907 27-1341991 (State or other jurisdiction of i |
|
| May 3, 2016 |
EX-10.1 Exhibit 10.1 Execution Version VOTING AGREEMENT This VOTING AGREEMENT, dated as of May 3, 2016 (this “Agreement”), among IMS Health Holdings, Inc., a Delaware corporation (“IMS Health”), and the shareholders of Quintiles Transnational Holdings Inc., a North Carolina corporation (“Quintiles”), listed on Schedule A hereto (each, a “Quintiles Shareholder” and, collectively, the “Quintiles Sha |
|
| May 3, 2016 |
Investor Briefing May 3, 2016 Exhibit 99.2 Cautionary Statements Regarding Forward Looking Statements This communication contains ?forward-looking statements? within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address |
|
| May 3, 2016 |
EX-2.1 Exhibit 2.1 Execution Version AGREEMENT AND PLAN OF MERGER by and between IMS HEALTH HOLDINGS, INC. and QUINTILES TRANSNATIONAL HOLDINGS INC. Dated as of May 3, 2016 TABLE OF CONTENTS ARTICLE I THE MERGER 2 Section 1.1 The Merger 2 Section 1.2 Closing 2 Section 1.3 Effective Time 2 Section 1.4 Effects of the Merger 3 Section 1.5 Charter; Bylaws 3 Section 1.6 Directors and Officers 3 Section |
|
| May 3, 2016 |
FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT EX-10.7 Exhibit 10.7 FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT This First Amendment to Executive Employment Agreement (“Amendment”) is made and entered into as of May , 2016 (the “Effective Date”) by and among Quintiles Transnational Corp., a North Carolina corporation (the “Company”), Quintiles Transnational Holdings, Inc. (“Parent”) and Thomas Pike (“Executive”). WHEREAS, Executive is cu |
|
| May 3, 2016 |
EX-99.1 Exhibit 99.1 News For Immediate Release Contacts: Tor Constantino Phil Bridges IMS Health Media Relations Quintiles Media Relations +1.484.567.6732 +1.919.998.1653 [email protected] [email protected] Tom Kinsley Todd Kasper IMS Health Investor Relations Quintiles Investor Relations +1.203.448.4691 +1.919.998.2590 [email protected] [email protected] I |
|
| May 3, 2016 |
EX-2.1 2 d161975dex21.htm EX-2.1 Exhibit 2.1 Execution Version AGREEMENT AND PLAN OF MERGER by and between IMS HEALTH HOLDINGS, INC. and QUINTILES TRANSNATIONAL HOLDINGS INC. Dated as of May 3, 2016 TABLE OF CONTENTS ARTICLE I THE MERGER 2 Section 1.1 The Merger 2 Section 1.2 Closing 2 Section 1.3 Effective Time 3 Section 1.4 Effects of the Merger 3 Section 1.5 Charter; Bylaws 3 Section 1.6 Direct |
|
| May 3, 2016 |
EX-10.1 3 d135044dex101.htm EX-10.1 Exhibit 10.1 Execution Version VOTING AGREEMENT This VOTING AGREEMENT, dated as of May 3, 2016 (this “Agreement”), among IMS Health Holdings, Inc., a Delaware corporation (“IMS Health”), and the shareholders of Quintiles Transnational Holdings Inc., a North Carolina corporation (“Quintiles”), listed on Schedule A hereto (each, a “Quintiles Shareholder” and, coll |
|
| May 3, 2016 |
EX-10.1 Exhibit 10.1 Execution Version VOTING AGREEMENT This VOTING AGREEMENT, dated as of May 3, 2016 (this “Agreement”), among IMS Health Holdings, Inc., a Delaware corporation (“IMS Health”), and the shareholders of Quintiles Transnational Holdings Inc., a North Carolina corporation (“Quintiles”), listed on Schedule A hereto (each, a “Quintiles Shareholder” and, collectively, the “Quintiles Sha |
|
| May 3, 2016 |
EX-10.3 5 d161975dex103.htm EX-10.3 Exhibit 10.3 Execution Version VOTING AGREEMENT This VOTING AGREEMENT, dated as of May 3, 2016 (this “Agreement”), among Quintiles Transnational Holdings Inc., a North Carolina corporation (“Quintiles”), and the shareholders of IMS Health Holdings, Inc., a Delaware corporation (“IMS Health”), listed on Schedule A hereto (each, a “Shareholder” and, collectively, |
|
| May 3, 2016 |
EX-10.2 Exhibit 10.2 Execution Version VOTING AGREEMENT This VOTING AGREEMENT, dated as of May 3, 2016 (this “Agreement”), among IMS Health Holdings, Inc., a Delaware corporation (“IMS Health”), and the shareholders of Quintiles Transnational Holdings Inc., a North Carolina corporation (“Quintiles”), listed on Schedule A hereto (each, a “Quintiles Shareholder” and, collectively, the “Quintiles Sha |
|
| May 3, 2016 |
EX-2.1 Exhibit 2.1 Execution Version AGREEMENT AND PLAN OF MERGER by and between IMS HEALTH HOLDINGS, INC. and QUINTILES TRANSNATIONAL HOLDINGS INC. Dated as of May 3, 2016 TABLE OF CONTENTS ARTICLE I THE MERGER 2 Section 1.1 The Merger 2 Section 1.2 Closing 2 Section 1.3 Effective Time 2 Section 1.4 Effects of the Merger 3 Section 1.5 Charter; Bylaws 3 Section 1.6 Directors and Officers 3 Section |
|
| May 3, 2016 |
GOLDMAN SACHS BANK USA 200 West Street New York, New York 10282 EX-10.4 Exhibit 10.4 EXECUTION COPY GOLDMAN SACHS BANK USA 200 West Street New York, New York 10282 JPMORGAN CHASE BANK, N.A. 383 Madison Avenue New York, New York 10179 CONFIDENTIAL May 3, 2016 IMS Health Holdings, Inc. IMS Health Incorporated 83 Wooster Heights Road Danbury, Connecticut 06810 Attention: Jeffrey Ford Project Cooperstown Commitment Letter Ladies and Gentlemen: You have advised Gol |
|
| May 3, 2016 |
GOLDMAN SACHS BANK USA 200 West Street New York, New York 10282 EX-10.4 Exhibit 10.4 EXECUTION COPY GOLDMAN SACHS BANK USA 200 West Street New York, New York 10282 JPMORGAN CHASE BANK, N.A. 383 Madison Avenue New York, New York 10179 CONFIDENTIAL May 3, 2016 IMS Health Holdings, Inc. IMS Health Incorporated 83 Wooster Heights Road Danbury, Connecticut 06810 Attention: Jeffrey Ford Project Cooperstown Commitment Letter Ladies and Gentlemen: You have advised Gol |
|
| May 3, 2016 |
GOLDMAN SACHS BANK USA 200 West Street New York, New York 10282 EX-10.4 Exhibit 10.4 EXECUTION COPY GOLDMAN SACHS BANK USA 200 West Street New York, New York 10282 JPMORGAN CHASE BANK, N.A. 383 Madison Avenue New York, New York 10179 CONFIDENTIAL May 3, 2016 IMS Health Holdings, Inc. IMS Health Incorporated 83 Wooster Heights Road Danbury, Connecticut 06810 Attention: Jeffrey Ford Project Cooperstown Commitment Letter Ladies and Gentlemen: You have advised Gol |
|
| May 3, 2016 |
8-K 1 d135044d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2016 IMS Health Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36381 27-1335689 (State or other jurisdiction o |
|
| May 3, 2016 |
EX-10.3 Exhibit 10.3 Execution Version VOTING AGREEMENT This VOTING AGREEMENT, dated as of May 3, 2016 (this “Agreement”), among IMS Health Holdings, Inc., a Delaware corporation (“IMS Health”), and Dennis B. Gillings, CBE (the “Quintiles Shareholder”). RECITALS WHEREAS, concurrently herewith, IMS Health and Quintiles Transnational Holdings Inc., a North Carolina corporation (“Quintiles”), are ent |
|
| May 3, 2016 |
Exhibit 99.1 News For Immediate Release Contacts: Tor Constantino Phil Bridges IMS Health Media Relations Quintiles Media Relations +1.484.567.6732 +1.919.998.1653 [email protected] [email protected] Tom Kinsley Todd Kasper IMS Health Investor Relations Quintiles Investor Relations +1.203.448.4691 +1.919.998.2590 [email protected] [email protected] IMS Healt |
|
| May 3, 2016 |
Quintiles Transitional Holdings 425 (Prospectus) Filed by Quintiles Transnational Holdings Inc. pursuant to Rule 425 of the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: IMS Health Holdings, Inc. Commission File No.: 001-36381 The following forms of emails were made available to representatives of Quintiles Transnational Holdings, Inc. on May 2, 20 |
|
| April 8, 2016 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 8, 2016 IMS Health Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36381 27-1335689 (State or other jurisdiction of incorporation) (Commission |
|
| February 22, 2016 |
IMS Health Holdings ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS DEFA14A 1 ims-defa14a040816.htm ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS *** Exercise Your Right to Vote *** Important Notice Regarding the Availability of Proxy Materials for the Stockholder Meeting to Be Held on April 08, 2016 IMS HEALTH HOLDINGS, INC. IMS HEALTH HOLDINGS, INC. 83 WOOSTER HEIGHTS ROAD DANBURY CT 06810 Meeting Information Meeting Type: Annual Meeting For holders as of: Fe |
|
| February 22, 2016 |
IMS Health Holdings DEFINITIVE PROXY STATEMENT DEF 14A 1 ims-def14a040816.htm DEFINITIVE PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check th |
|
| February 19, 2016 |
Exhibit 10.33 IMS HEALTH HOLDINGS, INC. 2010 EQUITY INCENTIVE PLAN Amendment No. 1 to Restricted Stock Unit Award Agreement This Amendment No. 1 to Restricted Stock Unit Award Agreement between IMS Health Holdings, Inc. (the “Company”) and Ari Bousbib ("Participant") is entered into as of this 31st day of December, 2015. WHEREAS, the Company and Participant desire to amend the terms of the Restric |
|
| February 19, 2016 |
Exhibit 10.36 Name of Participant: Ari Bousbib Grant Date: December 31, 2015 IMS HEALTH HOLDINGS, INC. 2014 INCENTIVE AND STOCK AWARD PLAN Restricted Stock Agreement Pursuant to the IMS Health Holdings, Inc. 2014 Incentive and Stock Award Plan (as amended from time to time, the “Plan”), IMS Health Holdings, Inc. (the “Company”) has granted to the Participant named above, on the grant date set fort |
|
| February 19, 2016 |
Stock Appreciation Rights Agreement between IMS Health Holdings, Inc. and Ari Exhibit 10.34 Name of Participant: Ari Bousbib IMS HEALTH HOLDINGS, INC. 2014 INCENTIVE AND STOCK AWARD PLAN Stock Appreciation Rights Agreement Pursuant to the IMS Health Holdings, Inc. 2014 Incentive and Stock Award Plan (as amended from time to time, the “Plan”), IMS Health Holdings, Inc. (the “Company”) has granted to the Participant named above, on the grant date listed on Exhibit A hereto (t |
|
| February 19, 2016 |
Exhibit 10.35 IMS HEALTH HOLDINGS, INC. 2014 INCENTIVE AND STOCK AWARD PLAN Amendment No. 1 to Stock Appreciation Rights Agreement This Amendment No. 1 to Stock Appreciation Rights Agreement between IMS Health Holdings, Inc. (the “Company”) and Ari Bousbib (“Participant”) is entered into as of this 31st day of December, 2015. WHEREAS, the Company and Participant desire to amend the terms of the St |
|
| February 19, 2016 |
IMS HEALTH HOLDINGS, INC. List of Subsidiaries Exhibit 21 IMS HEALTH HOLDINGS, INC. List of Subsidiaries Name of Subsidiary State or Jurisdiction of Incorporation Albatross Financial Solutions Limited United Kingdom AMIX S.a.r.l. France Appature, Inc. Washington Asesorias IMS Health Chile Limitada Chile Asserta Centroamerica Medicion de Mercados, S.A. Guatemala Battaerd Mansley Pty. Ltd. Australia Buzzeopdma LLC Delaware Cambridge Pharma Consu |
|
| February 19, 2016 |
IMS Health Holdings 10-K (Annual Report) 10-K 1 ims-10k20151231.htm 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File |
|
| February 12, 2016 |
IMS / IMS Health Holdings, Inc. / CANADA PENSION PLAN INVESTMENT BOARD - SC 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b),(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 1)* IMS Health Holdings, Inc. (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 44970B109 (CUSIP Number) December 31, 2 |
|
| February 12, 2016 |
IMS / IMS Health Holdings, Inc. / Green Equity Investors V, L.P. - SC 13G/A Passive Investment SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* IMS Health Holdings, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 44970B109 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to des |
|
| February 12, 2016 |
IMS / IMS Health Holdings, Inc. / TPG Group Holdings (SBS) Advisors, Inc. Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. 1)* Under the Securities Exchange Act of 1934 IMS Health Holdings, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Titles of Class of Securities) 44970B109 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate t |
|
| February 11, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* IMS Health Holdings, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 44970B109 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which t |
|
| February 4, 2016 |
IMS / IMS Health Holdings, Inc. / GIC Private Ltd - SC 13G/A Passive Investment SC 13G/A SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G/A (RULE 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) and (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 (Amendment No. |
|
| February 3, 2016 |
IMS Health Holdings IMS HEALTH HOLDINGS, INC. 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 February 3, 2016 Date of Report (Date of earliest event reported) IMS Health Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36381 27-1335689 (State or other jurisdiction (Commission File Number) (I |
|
| February 3, 2016 |
IMS Health Reports Fourth-Quarter and Full-Year 2015 Results, Issues Full-Year 2016 Guidance Exhibit 99.1 IMS Health Reports Fourth-Quarter and Full-Year 2015 Results, Issues Full-Year 2016 Guidance Revenue up 28.3 percent for the fourth quarter and 21.0 percent for the full year at constant currency Adjusted EBITDA up 16.8 percent for the fourth quarter and 11.2 percent for the full year at constant currency Adjusted Net Income up 11.8 percent in the fourth quarter and 24.6 percent for t |
|
| January 21, 2016 |
INCREMENTAL AMENDMENT NO. 2 TO CREDIT AGREEMENT EX-10.1 Exhibit 10.1 EXECUTION VERSION INCREMENTAL AMENDMENT NO. 2 TO CREDIT AGREEMENT INCREMENTAL AMENDMENT NO. 2, dated as of January 15, 2016 (this ?Amendment?), to the Third Amended and Restated Credit Agreement, dated as of March 17, 2014 (as amended by that certain Incremental Amendment No. 1 thereto, dated as of May 11, 2015, and as further amended, restated, supplemented or otherwise modif |
|
| January 21, 2016 |
IMS Health Holdings FORM 8-K (Current Report/Significant Event) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 January 21, 2016 (January 15, 2016) Date of Report (Date of earliest event reported) IMS Health Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36381 27-1335689 (State or other jurisdiction |
|
| December 17, 2015 |
IMS Health Announces $250 Million Share Repurchase Authorization EX-99.1 2 a51245632ex991.htm EXHIBIT 99.1 Exhibit 99.1 IMS Health Announces $250 Million Share Repurchase Authorization DANBURY, Conn.-(BUSINESS WIRE)-December 17, 2015-IMS Health Holdings, Inc. (NYSE:IMS) today announced that its board of directors approved a stock repurchase program authorizing the repurchase of up to $250 million of its common stock. The share repurchase program does not obliga |
|
| December 17, 2015 |
Financial Statements and Exhibits, Other Events 8-K 1 a51245632.htm IMS HEALTH HOLDINGS, INC. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 December 17, 2015 (December 16, 2015) Date of Report (Date of earliest event reported) IMS Health Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36 |
|
| December 16, 2015 |
IMS Health Holdings FORM 8-K (Current Report/Significant Event) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 December 16, 2015 Date of Report (Date of earliest event reported) IMS Health Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36381 27-1335689 (State or other jurisdiction (Commission File |
|
| November 4, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ‘ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36381 IMS |
|
| October 29, 2015 |
IMS Health Reports Third-Quarter 2015 Results Exhibit 99.1 IMS Health Reports Third-Quarter 2015 Results Revenue up 23 percent at constant currency Adjusted EBITDA up 8.6 percent at constant currency Adjusted Net Income up 10.6 percent at constant currency Adjusted Diluted Earnings per Share: $0.38 Guidance reaffirmed for Revenue and at upper end of Adjusted Net Income and Diluted EPS ranges DANBURY, Conn.-(BUSINESS WIRE)-October 29, 2015-IMS |
|
| October 29, 2015 |
IMS Health Holdings IMS HEALTH HOLDINGS, INC. 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 October 29, 2015 Date of Report (Date of earliest event reported) IMS Health Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36381 27-1335689 (State or other jurisdiction (Commission File Number) (I |
|
| August 11, 2015 |
IMS Health Holdings FORM 8-K (Current Report/Significant Event) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2015 (August 5, 2015) IMS Health Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36381 27-1335689 (State or other jurisdiction o |
|
| August 11, 2015 |
IMS HEALTH HOLDINGS, INC. 20,000,000 Shares of Common Stock Underwriting Agreement EX-1.1 Exhibit 1.1 Execution Version IMS HEALTH HOLDINGS, INC. 20,000,000 Shares of Common Stock Underwriting Agreement August 5, 2015 J.P. Morgan Securities LLC 383 Madison Avenue New York, New York 10179 Morgan Stanley & Co. LLC 1585 Broadway New York, New York 10036 Ladies and Gentlemen: The stockholders of IMS Health Holdings, Inc., a Delaware corporation (the ?Company?) named in Schedule 2 he |
|
| August 7, 2015 |
424B7 1 d41511d424b7.htm PROSPECTUS SUPPLEMENT Table of Contents CALCULATION OF REGISTRATION FEE Title of Securities to Be Registered Amount to be Registered Proposed Maximum Offering Price Per Share(1) Proposed Maximum Aggregate Offering Price Amount of Registration Fee Common Stock, par value $0.01 20,000,000 $31.14 $622,800,000 $72,369.36 (1) Estimated solely for purposes of calculating the amo |
|
| August 5, 2015 |
Subject to completion, dated August 5, 2015 424B7 1 d41511d424b7.htm PROSPECTUS SUPPLEMENT Table of Contents Filed Pursuant to Rule 424(b)(7) Registration File No. 333-203836 The information in this preliminary prospectus supplement and the accompanying prospectus is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these securities and are not soliciting an offe |
|
| August 4, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2015 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36381 IMS HEALTH |
|
| August 3, 2015 |
Submission of Matters to a Vote of Security Holders 8-K/A 1 d58905d8ka.htm FORM 8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A AMENDMENT NO. 1 CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 April 21, 2015 Date of Report (Date of earliest event reported) IMS Health Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36381 27-1335689 (State |
|
| July 31, 2015 |
IMS Health Holdings IMS HEALTH HOLDINGS, INC. 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 July 31, 2015 Date of Report (Date of earliest event reported) IMS Health Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36381 27-1335689 (State or other jurisdiction (Commission File Number) (I.R. |
|
| July 31, 2015 |
IMS Health Reports Second-Quarter 2015 Results EX-99.1 2 a51153747ex991.htm EXHIBIT 99.1 Exhibit 99.1 IMS Health Reports Second-Quarter 2015 Results Revenue up 24.6 percent at constant currency Adjusted EBITDA up 9.5 percent at constant currency Adjusted Net Income up 3.9 percent at constant currency Adjusted Diluted Earnings per Share: $0.37 2015 full-year guidance reaffirmed High teens cash tax rate guidance extended by two years through mid |
|
| May 15, 2015 |
Exhibit 4.1 INDENTURE Dated as of March 30, 2015 Among IMS Health Incorporated, as Issuer, the Guarantors party hereto, Deutsche Trustee Company Limited, as Trustee, Deutsche Bank AG, London Branch, as Paying Agent And Deutsche Bank Luxembourg S.A., as Registrar and Transfer Agent 4.125% SENIOR NOTES DUE 2023 Table of contents Page ARTICLE I DEFINITIONS AND INCORPORATION BY REFERENCE SECTION 1.01. |
|
| May 15, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2015 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36381 IMS HEALT |
|
| May 15, 2015 |
INCREMENTAL AMENDMENT NO. 1 TO CREDIT AGREEMENT Exhibit 10.1 INCREMENTAL AMENDMENT NO. 1 TO CREDIT AGREEMENT INCREMENTAL AMENDMENT NO. 1, dated as of May 11, 2015 (this “Amendment”), to the Third Amended and Restated Credit Agreement, dated as of March 17, 2014 (as amended, restated, supplemented or otherwise modified prior to the date hereof), among IMS Health Incorporated, a Delaware corporation (the “Parent Borrower”), Healthcare Technology |
|
| May 12, 2015 |
8-K 1 d923288d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 12, 2015 (May 6, 2015) IMS Health Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36381 27-1335689 (State or other |
|
| May 12, 2015 |
IMS HEALTH HOLDINGS, INC. 51,100,000 Shares of Common Stock Underwriting Agreement EX-1.1 2 d923288dex11.htm EX-1.1 Exhibit 1.1 Execution Version IMS HEALTH HOLDINGS, INC. 51,100,000 Shares of Common Stock Underwriting Agreement May 6, 2015 Goldman, Sachs & Co. J.P. Morgan Securities LLC Morgan Stanley & Co. LLC As Representatives of the several Underwriters listed in Schedule 1 hereto c/o Goldman, Sachs & Co. 200 West Street New York, New York 10282 J.P. Morgan Securities LLC 3 |
|
| May 8, 2015 |
Prospectus Supplement Table of Contents Filed Pursuant to Rule 424(b)(7) Registration File No. |
|
| May 7, 2015 |
IMS Health Announces Pricing of Secondary Public Offering and Repurchase of Common Stock Free Writing Prospectus Free Writing Prospectus Dated May 6, 2015 Filed Pursuant to Rule 433 Registration Statement No. |
|
| May 4, 2015 |
Table of Contents Filed Pursuant to Rule 424(b)(7) Registration File No. 333-203836 The information in this preliminary prospectus supplement and the accompanying prospectus is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these securities and are not soliciting an offer to buy these securities in any jurisdiction w |
|
| May 4, 2015 |
Table of Contents Filed with the Securities and Exchange Commission on May 4, 2015 Registration No. |
|
| May 4, 2015 |
Form 8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) April 1, 2015 IMS Health Holdings, Inc. (Exact name of registrant as specified in charter) Delaware 001-36381 27-1335689 (State or Other Jurisdiction of Incorporation) (Co |
|
| May 4, 2015 |
IMS HEALTH HOLDINGS, INC. UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Exhibit 99.2 IMS HEALTH HOLDINGS, INC. UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION On April 1, 2014, IMS Health Holdings, Inc. (?IMS Health? or the ?Company?) acquired certain customer relationship management and strategic data businesses of Cegedim, SA (?Cegedim? and the ?Cegedim acquisition?) for ?385 million plus an initial working capital adjustment of ?11 million. The Cegedim |
|
| May 4, 2015 |
IMS Health Announces Launch of Secondary Public Offering and Repurchase of Common Stock FWP 1 d918227dfwp.htm FREE WRITING PROSPECTUS Free Writing Prospectus Dated May 4, 2015 Filed Pursuant to Rule 433 Registration Statement No. 333-203836 News For Immediate Release Contacts: Tom Kinsley Tor Constantino Investor Relations Media Relations +1.203.448.4691 +1.484.567.6732 [email protected] [email protected] IMS Health Announces Launch of Secondary Public Offering and R |
|
| May 4, 2015 |
EX-99.1 2 d919873dex991.htm EX-99.1 Table of Contents Exhibit 99.1 CRM and Strategic Data Combined Financial Statements as of and for the years ended December 31, 2014, 2013 and 2012. Table of Contents MAZARS 61, rue Henri Regnault 92400 Courbevoie S.A au capital de € 8.320.000 Commissaire aux Comptes Membre de la compagnie Régionale de Versailles CEGEDIM Year ended December 31, 2014, 2013 and 201 |
|
| April 27, 2015 |
IMS Health Holdings FORM 8-K (Current Report/Significant Event) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 21, 2015 IMS Health Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36381 27-1335689 (State or other jurisdiction of incorporation) ( |
|
| April 24, 2015 |
IMS Health Holdings IMS HEALTH HOLDINGS, INC. 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 April 24, 2015 Date of Report (Date of earliest event reported) IMS Health Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36381 27-1335689 (State or other jurisdiction (Commission File Number) (I.R |
|
| April 24, 2015 |
IMS Health Reports First-Quarter 2015 Results Exhibit 99.1 IMS Health Reports First-Quarter 2015 Results Revenue up 7.0 percent at constant currency Adjusted EBITDA up 9.8 percent at constant currency Adjusted Net Income up 116 percent at constant currency Adjusted Diluted Earnings per Share was $0.39, up 15 cents DANBURY, Conn.-(BUSINESS WIRE)-April 24, 2015-IMS Health Holdings, Inc. (?IMS Health?) (NYSE:IMS), a leading global provider of in |
|
| April 10, 2015 |
Unassociated Document POWER OF ATTORNEY The undersigned hereby constitutes and appoints Harvey A. |
|
| April 6, 2015 |
POWER OF ATTORNEY The undersigned hereby constitutes and appoints Harvey A. Ashman and Robin Nance with full power of substitution, as the undersigned's true and lawful attorney-in-fact to: (1) prepare, execute in the undersigned's name and on the undersigned's behalf, and submit to the U.S. Securities and Exchange Commission (the "SEC") a Form ID, including amendments thereto, and any other docum |
|
| April 1, 2015 |
8-K 1 d902207d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) March 30, 2015 IMS Health Holdings, Inc. (Exact name of registrant as specified in charter) Delaware 001-36381 27-1335689 (State or Other Jurisdiction of |
|
| March 30, 2015 |
Karen Katen Joins IMS Health Board of Directors Exhibit 99.1 Karen Katen Joins IMS Health Board of Directors DANBURY, Conn.-(BUSINESS WIRE)-March 30, 2015-IMS Health (NYSE:IMS) announced the appointment of Karen Katen to its board of directors, effective today. A senior pharmaceutical industry executive at Pfizer for more than three decades, Karen retired in 2007 as vice chairman of Pfizer Inc. and president of Pfizer Human Health. ?We are very |
|
| March 30, 2015 |
IMS Health Holdings IMS HEALTH HOLDINGS, INC. 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 27, 2015 IMS Health Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36381 27-1335689 (State or other jurisdiction (Commission File Number) (I. |
|
| March 27, 2015 |
8-K 1 d900079d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 27, 2015 IMS Health Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36381 27-1335689 (State or other jurisdictio |
|
| March 20, 2015 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events 8-K 1 a51062828.htm IMS HEALTH HOLDINGS, INC. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) March 17, 2015 IMS Health Holdings, Inc. (Exact name of registrant as specified in charter) Delaware 001-36381 27-1335689 (State or Ot |
|
| March 20, 2015 |
Exhibit 99.1 IMS Health Announces Pricing of Senior Notes to Finance Proposed Acquisition of Cegedim?s CRM and Strategic Data Businesses DANBURY, Conn.-(BUSINESS WIRE)-March 19, 2015-IMS Health Holdings, Inc. (NYSE:IMS) today announced the pricing of its offering of ?275 million in gross proceeds of senior notes to be issued by its wholly-owned subsidiary, IMS Health Incorporated. The net proceeds |
|
| March 16, 2015 |
Financial Statements and Exhibits, Other Events 8-K 1 a51059061.htm IMS HEALTH HOLDINGS, INC. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) March 16, 2015 IMS Health Holdings, Inc. (Exact name of registrant as specified in charter) Delaware 001-36381 27-1335689 (State or Ot |
|
| March 16, 2015 |
Exhibit 99.1 IMS Health Announces Offering of Senior Notes to Finance Proposed Acquisition of Cegedim’s CRM and Strategic Data Businesses DANBURY, Conn.-(BUSINESS WIRE)-March 16, 2015-IMS Health Holdings, Inc. (NYSE:IMS) today announced that its wholly-owned subsidiary, IMS Health Incorporated, intends to raise €275 million in gross proceeds through an offering of senior notes due 2023. The net pr |
|
| March 3, 2015 |
IMS / IMS Health Holdings, Inc. DEFA14A - - DEFA 14A DEFA 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement |
|
| March 3, 2015 |
IMS / IMS Health Holdings, Inc. DEF 14A - - DEF 14A DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| February 13, 2015 |
IMS / IMS Health Holdings, Inc. / CANADA PENSION PLAN INVESTMENT BOARD - SC 13G Passive Investment SC 13G SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b),(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) IMS Health Holdings, Inc. (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 44970B109 (CUSIP Number) December 31, 2014 (Date of |
|
| February 13, 2015 |
IMS / IMS Health Holdings, Inc. / TPG Group Holdings (SBS) Advisors, Inc. Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. )* Under the Securities Exchange Act of 1934 IMS Health Holdings, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Titles of Class of Securities) 44970B109 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate th |
|
| February 13, 2015 |
IMS / IMS Health Holdings, Inc. / Green Equity Investors V, L.P. - SC 13G Passive Investment SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. )* IMS Health Holdings, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 44970B109 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to design |
|
| February 13, 2015 |
EX-99.1 Exhibit 99.1 JOINT FILING AGREEMENT We, the signatories of the Statement on Schedule 13G to which this Joint Filing Agreement is attached, hereby agree that such statement is, and any amendments thereto filed by any of us will be, filed on behalf of each of us pursuant to and in accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended. Date: February 13, 2015 |
|
| February 13, 2015 |
EX-99.1 Exhibit 1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned agree as follows: (i) Each party executing this joint filing agreement (the “Agreement”) is individually eligible to use the Schedule 13G to which this Exhibit is attached (the “13G”) and the 13G, including amendments thereto, is filed on b |
|
| February 13, 2015 |
IDENTIFICATION OF MEMBERS OF THE GROUP EX-99.3 Exhibit 3 IDENTIFICATION OF MEMBERS OF THE GROUP The following filing persons may be deemed to be members of a “group” under Section 13(d) of the Securities Exchange Act of 1934, as amended: The parties to that certain Amended and Restated Shareholders’ Agreement, dated as of April 9, 2014, which was filed as Exhibit 10.1 to the IMS Health Holdings, Inc. Registration Statement on Form S-1 |
|
| February 13, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36381 IMS HEALTH HOL |
|
| February 13, 2015 |
EX-99.2 Exhibit 2 POWER OF ATTORNEY Know all by these presents, that each of the undersigned hereby constitutes and appoints each of Lance J.T. Schumacher, Cody L. Franklin and Adrian J. Maizey signing singly, as the undersigned’s true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer, director, or beneficial owner of the |
|
| February 12, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* IMS Health Holdings, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 44970B109 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which thi |
|
| February 11, 2015 |
IMS / IMS Health Holdings, Inc. / GIC Private Ltd - SC 13G/A Passive Investment SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A (RULE 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) and (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 (Amendment No. |
|
| February 10, 2015 |
Form of IMS Performance Share Award Agreement under the 2014 Incentive and Stock Award Plan. EX-10.2 Exhibit 10.2 Name of Participant: IMS HEALTH HOLDINGS, INC. 2014 INCENTIVE AND STOCK AWARD PLAN Performance Share Award Agreement Pursuant to the IMS Health Holdings, Inc. 2014 Incentive and Stock Award Plan (as amended from time to time, the “Plan”), IMS Health Holdings, Inc. (the “Company”) has granted to the Participant named above, on the grant date listed on Exhibit A attached hereto |
|
| February 10, 2015 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 February 7, 2015 Date of report (date of earliest event reported) IMS Health Holdings, Inc. |
|
| February 10, 2015 |
Form of IMS Stock Appreciation Rights Agreement under the 2014 Incentive and Stock Award Plan. EX-10.1 2 d867587dex101.htm EX-10.1 Exhibit 10.1 Name of Participant: IMS HEALTH HOLDINGS, INC. 2014 INCENTIVE AND STOCK AWARD PLAN Stock Appreciation Rights Agreement Pursuant to the IMS Health Holdings, Inc. 2014 Incentive and Stock Award Plan (as amended from time to time, the “Plan”), IMS Health Holdings, Inc. (the “Company”) has granted to the Participant named above, on the grant date listed |
|
| February 3, 2015 |
IMS Health Reports Fourth-Quarter and Full-Year 2014 Results, Issues Full-Year 2015 Guidance Exhibit 99.1 IMS Health Reports Fourth-Quarter and Full-Year 2014 Results, Issues Full-Year 2015 Guidance Revenue increased 6.2 percent for the fourth quarter and 5.9 percent for the full year on a constant currency basis Adjusted EBITDA increased 8.5 percent for the fourth quarter and 9.5 percent for the full year at constant currency Adjusted Net Income increased 70 percent in the fourth quarter |
|
| February 3, 2015 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 February 3, 2015 Date of report (date of earliest event reported) IMS Health Holdings, Inc. |
|
| February 2, 2015 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 27, 2015 IMS Health Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36381 27-1335689 (State or other jurisdiction of incorporation) |
|
| December 22, 2014 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 17, 2014 IMS Health Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36381 27-1335689 (State or other jurisdiction of incorporation |
|
| October 30, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2014 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36381 IMS H |
|
| October 24, 2014 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 a50969015.htm IMS HEALTH HOLDINGS, INC. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 October 24, 2014 Date of report (date of earliest event reported) IMS Health Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36381 27-1335689 (State o |
|
| October 24, 2014 |
IMS Health Reports Third-Quarter 2014 Results Exhibit 99.1 IMS Health Reports Third-Quarter 2014 Results Adjusted Net Income for the quarter totaled $125 million and Adjusted Diluted Earnings per Share was $0.37 Revenue up 5.4 percent and Adjusted EBITDA increased 10.5 percent on a constant currency basis DANBURY, Conn.-(BUSINESS WIRE)-October 24, 2014-IMS Health Holdings, Inc. (“IMS Health”) (NYSE:IMS), a leading global provider of informati |
|
| October 23, 2014 |
IMS / IMS Health Holdings, Inc. / GIC Private Ltd - SC 13G Passive Investment SC 13G SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G/ (RULE 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) and (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 (Amendment No. |
|
| October 17, 2014 |
EX-99.1 EXHIBIT 99.1 News For Immediate Release Contacts: Tor Constantino Tom Kinsley Media Relations Investor Relations +1.484.567.6732 +1.203.448.4691 [email protected] [email protected] IMS Health Offer to Purchase Cegedim’s Information Solutions and CRM Businesses Approved by Cegedim Board DANBURY, CT, October 17, 2014 – IMS Health (NYSE:IMS) today announced that following suc |
|
| October 17, 2014 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 17, 2014 IMS Health Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36381 27-1335689 (State or other jurisdiction of incorporation) |
|
| July 30, 2014 |
EX-10.1 2 exhibit101.htm EX-10.1 Exhibit 10.1 PUT OPTION AGREEMENT dated as of June 24, 2014 between IMS HEALTH INCORPORATED and CEGEDIM SA TABLE OF CONTENTS ARTICLE I INTERPRETATION 1 ARTICLE II PUT OPTION 1 ARTICLE III PURCHASE PRICE 2 ARTICLE IV EXERCISE OF THE PUT OPTION 2 4.1 Exercise Period 2 4.2 Expiration of Put Option 2 4.3 Further Provisions 2 ARTICLE V EXECUTION OF DRAFT MAA 3 ARTICLE V |
|
| July 30, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2014 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36381 IMS HEALTH |
|
| July 24, 2014 |
IMS Health Reports Second-Quarter 2014 Results Exhibit 99.1 IMS Health Reports Second-Quarter 2014 Results Revenue for the quarter increased 6.1 percent to $662 million Adjusted EBITDA improved 9.2 percent to $226 million DANBURY, Conn.-(BUSINESS WIRE)-July 24, 2014-IMS Health Holdings, Inc. (“IMS Health”) (NYSE:IMS), a leading global provider of information and technology services to the healthcare and life sciences industries, today announce |
|
| July 24, 2014 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 July 24, 2014 Date of report (date of earliest event reported) IMS Health Holdings, Inc. |
|
| June 30, 2014 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2014 IMS Health Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36381 27-1335689 (State or other jurisdiction of incorporation) (C |
|
| June 30, 2014 |
EX-99.1 Exhibit 99.1 IMS Health to Acquire Cegedim’s Information Solutions and CRM Businesses 06/24/2014 DANBURY, Conn.–(BUSINESS WIRE)– IMS Health (NYSE:IMS), a leading global provider of information and technology services to the healthcare and life sciences industries, today announced its intention to acquire certain Cegedim information solutions and Customer Relationship Management (CRM) busin |
|
| May 2, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2014 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0 |
|
| May 1, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 May 1, 2014 Date of report (date of earliest event reported) IMS Health Holdings, Inc. |
|
| May 1, 2014 |
IMS Health Reports First-Quarter 2014 Results and Provides Full-Year Guidance EX-99.1 2 a50854982ex991.htm EXHIBIT 99.1 Exhibit 99.1 IMS Health Reports First-Quarter 2014 Results and Provides Full-Year Guidance Revenue for the quarter increased 5.2 percent to $645 million, up 6.6 percent on a constant currency basis Adjusted EBITDA for the quarter increased 7.2 percent to $217 million, up 9.5 percent on a constant currency basis Full-year 2014 guidance of 5 to 6 percent rev |
|
| April 9, 2014 |
EX-10.1 5 d708075dex101.htm EX-10.1 Exhibit 10.1 THIS AMENDED AND RESTATED SHAREHOLDERS’ AGREEMENT (as it may be amended from time to time in accordance with the terms hereof, the “Agreement”), dated as of April 9, 2014, is made by and among TPG, CPPIB and LGP (each as defined herein) (collectively, the “Sponsors”) and IMS Health Holdings, Inc. (the “Company”). RECITALS WHEREAS, on February 26, 20 |
|
| April 9, 2014 |
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION IMS HEALTH HOLDINGS, INC. EX-3.1 Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF IMS HEALTH HOLDINGS, INC. IMS Health Holdings, Inc., a Delaware corporation (the “Corporation”), hereby certifies that this Amended and Restated Certificate of Incorporation has been duly adopted in accordance with Sections 242 and 245 of the General Corporation Law of the State of Delaware (the “DGCL”), and that: A. The name |
|
| April 9, 2014 |
AMENDMENT TO REGISTRATION AND PREEMPTIVE RIGHTS AGREEMENT EX-4.1 4 d708075dex41.htm EX-4.1 Exhibit 4.1 AMENDMENT TO REGISTRATION AND PREEMPTIVE RIGHTS AGREEMENT This AMENDMENT TO REGISTRATION AND PREEMPTIVE RIGHTS AGREEMENT (this “Amendment”) is entered into as of April 9, 2014, by and among IMS Health Holdings, Inc. (formerly Healthcare Technology Holdings, Inc., the “Company”) and certain stockholders of the Company (the “Stockholders”). This Amendment |
|
| April 9, 2014 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 April 9, 2014 Date of report (date of earliest event reported) IMS Health Holdings, Inc. |
|
| April 9, 2014 |
AMENDED AND RESTATED BYLAWS IMS HEALTH HOLDINGS, INC. SECTION 1 - STOCKHOLDERS EX-3.2 Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF IMS HEALTH HOLDINGS, INC. SECTION 1 - STOCKHOLDERS Section 1.1. Annual Meeting. An annual meeting of the stockholders of IMS Health Holdings, Inc., a Delaware corporation (the “Corporation”), for the election of directors to succeed those whose term expire and for the transaction of such other business as may properly come before the meeting shall |
|
| April 9, 2014 |
S-8 1 d708101ds8.htm S-8 As filed with the Securities and Exchange Commission on April 9, 2014 Registration No. 333 - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 IMS HEALTH HOLDINGS, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 27-1335689 ( State or Other Jurisdiction of Incorporati |
|
| April 4, 2014 |
424B4 Table of Contents Filed Pursuant to Rule 424(b)(4) Registration No. 333-193159 65,000,000 shares IMS Health Holdings, Inc. Common stock $20.00 per share This is the initial public offering of our common stock. We are selling 52,000,000 shares of our common stock. The selling stockholders identified in this prospectus are offering an additional 13,000,000 shares of our common stock. We will n |
|
| March 31, 2014 |
CORRESP March 31, 2014 VIA EDGAR AND E-MAIL Securities and Exchange Commission Division of Corporate Finance 100 F Street, N. |
|
| March 31, 2014 |
CORRESP March 31, 2014 VIA EDGAR AND E-MAIL Mr. Gabriel Eckstein U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: IMS Health Holdings, Inc. (the “Company”) Registration Statement on Form S-1 File No. 333-193159 Dear Mr. Eckstein: In connection with the above-referenced Registration Statement, we wish to advise you that between Ma |
|
| March 27, 2014 |
8-A12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A For Registration of Certain Classes of Securities Pursuant to Section 12(b) or 12(g) of the Securities Exchange Act of 1934 IMS HEALTH HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 27-1335689 (State of Incorporation) (I.R.S. Employer Identification No.) 80 Wooster Heights Road D |
|
| March 24, 2014 |
AMENDED AND RESTATED BYLAWS IMS HEALTH HOLDINGS, INC. SECTION 1 - STOCKHOLDERS EX-3.2 Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF IMS HEALTH HOLDINGS, INC. SECTION 1 - STOCKHOLDERS Section 1.1. Annual Meeting. An annual meeting of the stockholders of IMS Health Holdings, Inc., a Delaware corporation (the “Corporation”), for the election of directors to succeed those whose term expire and for the transaction of such other business as may properly come before the meeting shall |
|
| March 24, 2014 |
AMENDMENT NO. 2 TO SECOND AMENDED AND RESTATED CREDIT AND GUARANTY AGREEMENT EX-10.31 10 d628679dex1031.htm EX-10.31 Exhibit 10.31 AMENDMENT NO. 2 TO SECOND AMENDED AND RESTATED CREDIT AND GUARANTY AGREEMENT AMENDMENT NO. 2 TO SECOND AMENDED AND RESTATED CREDIT AND GUARANTY AGREEMENT, dated as of March 17, 2014 (this “Amendment”), among IMS HEALTH INCORPORATED, a Delaware corporation (“Parent Borrower”), IMS AG, a Swiss corporation and a subsidiary of Parent Borrower (“Swi |
|
| March 24, 2014 |
EX-10.27 Exhibit 10.27 INDEMNIFICATION AGREEMENT This Indemnification Agreement (“Agreement”) is made and entered into as of [ ], by and among IMS Health Holdings, Inc., a Delaware corporation (the “Company”), Healthcare Technology Intermediate, Inc., a Delaware corporation, Healthcare Technology Intermediate Holdings, Inc., a Delaware corporation (together with Healthcare Technology Intermediate, |
|
| March 24, 2014 |
EX-10.1 Exhibit 10.1 AMENDED AND RESTATED SHAREHOLDERS’ AGREEMENT BY AND AMONG TPG PARTNERS V, L.P. TPG FOF V-A, L.P. TPG FOF V-B, L.P. TPG PARTNERS VI, L.P. TPG FOF VI SPV, L.P. TPG BIOTECHNOLOGY PARTNERS III, L.P. TPG ICEBERG CO-INVEST LLC CPP INVESTMENT BOARD PRIVATE HOLDINGS INC. GREEN EQUITY INVESTORS V, L.P. GREEN EQUITY INVESTORS SIDE V, L.P. LGP ICEBERG CO-INVEST, LLC AND IMS HEALTH HOLDIN |
|
| March 24, 2014 |
EX-10.3 Exhibit 10.3 EXECUTION COPY MANAGEMENT SERVICES AGREEMENT This Management Services Agreement (the “Agreement”) is entered into as of February 26, 2010 by and among Healthcare Technology Acquisition, Inc., a Delaware corporation (“Merger Sub”), Healthcare Technology Intermediate, Inc. (“Intermediate”), Healthcare Technology Intermediate Holdings, Inc. (together with Intermediate, “Intermedi |
|
| March 24, 2014 |
IMS HEALTH HOLDINGS, INC. [—] Shares of Common Stock Underwriting Agreement EX-1.1 Exhibit 1.1 IMS HEALTH HOLDINGS, INC. [—] Shares of Common Stock Underwriting Agreement [—], 2014 J.P. Morgan Securities LLC Goldman, Sachs & Co. Morgan Stanley & Co. LLC As Representatives of the several Underwriters listed in Schedule 1 hereto c/o J.P. Morgan Securities LLC 383 Madison Avenue New York, New York 10179 Goldman, Sachs & Co. 200 West Street New York, New York 10282 Morgan Sta |
|
| March 24, 2014 |
Amendment No. 3 to Form S-1 Table of Contents As filed with the Securities and Exchange Commission on March 24, 2014 Registration No. 333-193159 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 3 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 IMS HEALTH HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 7374 27-1 |
|
| March 24, 2014 |
EX-21.1 Exhibit 21.1 IMS Health Holdings, Inc. Active Subsidiaries as of March 24, 2014 Name State or Other Jurisdiction of Incorporation % Ownership 100% except as noted HEALTHCARE TECHNOLOGY INTERMEDIATE, INC. Delaware HEALTHCARE TECHNOLOGY INTERMEDIATE HOLDINGS, INC. Delaware IMS HEALTH INCORPORATED Delaware AMUNDSEN PUBLICATIONS L.L.C. Delaware APPATURE, INC. Washington COORDINATED MANAGEMENT |
|
| March 24, 2014 |
EX-10.32 Exhibit 10.32 Published Deal CUSIP NUMBER: 44969CAP5 Japanese Revolving Credit Facility CUSIP NUMBER: 44969CAR1 Swiss/Multicurrency Revolving Credit Facility CUSIP NUMBER: 44969CAS9 U.S. Revolving Credit Facility CUSIP NUMBER: 44969CAQ3 Term A Dollar Loan CUSIP NUMBER: 44969CAV2 Term A Euro Loan CUSIP NUMBER: 44969CAW0 Term B Dollar Loan CUSIP NUMBER: 44969CAT7 Term B Euro Loan CUSIP NUMB |
|
| March 24, 2014 |
EX-10.33 Exhibit 10.33 AMENDED AND RESTATED PLEDGE AND SECURITY AGREEMENT dated as of March 17, 2014 among HEALTHCARE TECHNOLOGY INTERMEDIATE HOLDINGS, INC., IMS HEALTH INCORPORATED, EACH OF THE GRANTORS PARTY HERETO and BANK OF AMERICA, N.A., as Administrative Agent TABLE OF CONTENTS Page SECTION 1. DEFINITIONS; GRANT OF SECURITY 1.1. GENERAL DEFINITIONS 1 1.2. DEFINITIONS; INTERPRETATION 5 SECTI |
|
| March 24, 2014 |
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION IMS HEALTH HOLDINGS, INC. EX-3.1 3 d628679dex31.htm EX-3.1 Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF IMS HEALTH HOLDINGS, INC. IMS Health Holdings, Inc., a Delaware corporation (the “Corporation”), hereby certifies that this Amended and Restated Certificate of Incorporation has been duly adopted in accordance with Sections 242 and 245 of the General Corporation Law of the State of Delaware (the “DGCL |
|
| March 24, 2014 |
AMENDMENT TO REGISTRATION AND PREEMPTIVE RIGHTS AGREEMENT EX-4.13 Exhibit 4.13 AMENDMENT TO REGISTRATION AND PREEMPTIVE RIGHTS AGREEMENT This AMENDMENT TO REGISTRATION AND PREEMPTIVE RIGHTS AGREEMENT (this “Amendment”) is entered into as of [ ], 2014, by and among IMS Health Holdings, Inc. (formerly Healthcare Technology Holdings, Inc., the “Company”) and certain stockholders of the Company (the “Stockholders”). This Amendment amends that certain Registr |
|
| March 24, 2014 |
the other Guarantors party thereto from time to time, and Bank of America, N.A., as Administrative EX-10.34 13 d628679dex1034.htm EX-10.34 Exhibit 10.34 U.S. GUARANTY dated as of March 17, 2014 among HEALTHCARE TECHNOLOGY INTERMEDIATE HOLDINGS, INC., as Holdings, IMS HEALTH INCORPORATED, as Parent Borrower THE OTHER GUARANTORS PARTY HERETO FROM TIME TO TIME, and BANK OF AMERICA, N.A., as Administrative Agent TABLE OF CONTENTS Page ARTICLE I Definitions 1 Section 1.01 Credit Agreement Definition |
|
| March 11, 2014 |
CORRESP ROPES & GRAY LLP PRUDENTIAL TOWER 800 BOYLSTON STREET BOSTON, MA 02199-3600 WWW. |
|
| March 10, 2014 |
Amendment No. 2 to Form S-1 Table of Contents As filed with the Securities and Exchange Commission on March 10, 2014 Registration No. 333-193159 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 2 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 IMS HEALTH HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 7374 27-1 |
|
| March 10, 2014 |
2014 IMS Health Annual Incentive Plan. EX-10.30 Exhibit 10.30 2014 IMS HEALTH - ANNUAL INCENTIVE COMPENSATION PLAN The 2014 IMS Health Annual Incentive Compensation Plan (the “Plan”) is directly linked to the Company’s growth and profitability objectives, and supports a culture where performance drives compensation. I. Plan Eligibility IMS employees are eligible to participate in the Plan, with the exception of employees who are on ano |
|
| March 10, 2014 |
IMS HEALTH HOLDINGS, INC. 2014 Incentive and Stock Award Plan EX-10.26 3 d628679dex1026.htm EX-10.26 Exhibit 10.26 IMS HEALTH HOLDINGS, INC. 2014 Incentive and Stock Award Plan 1. Purpose of the Plan. The purpose of this 2014 Incentive and Stock Award (the “Plan”) is to aid IMS Health Holdings, Inc., a Delaware corporation (the “Company”), in attracting, retaining, motivating and rewarding employees, non-employee directors and other persons who provide subst |
|
| March 10, 2014 |
EX-10.27 Exhibit 10.27 INDEMNIFICATION AGREEMENT This Indemnification Agreement (“Agreement”) is made and entered into as of [ ], by and among IMS Health Holdings, Inc., a Delaware corporation (the “Company”), Healthcare Technology Intermediate, Inc., a Delaware corporation, Healthcare Technology Intermediate Holdings, Inc., a Delaware corporation (together with Healthcare Technology Intermediate, |
|
| March 10, 2014 |
ROPES & GRAY LLP PRUDENTIAL TOWER 800 BOYLSTON STREET BOSTON, MA 02199-3600 WWW.ROPESGRAY.COM March 10, 2014 VIA EDGAR Gabriel Eckstein Staff Attorney United States Securities and Exchange Commission Division of Corporation Finance 100 F. Street, N.E. Washington, D.C. 20549 Re: IMS Health Holdings, Inc. Registration Statement on Form S-1, filed January 2, 2014 File No. 333-193159 Dear Mr. Eckstein |
|
| March 10, 2014 |
EX-10.28 Exhibit 10.28 Name of Participant: IMS HEALTH HOLDINGS, INC. 2010 EQUITY INCENTIVE PLAN THIS AWARD AND ANY SECURITIES DELIVERED HEREUNDER ARE SUBJECT TO RESTRICTIONS ON VOTING AND TRANSFER AND REQUIREMENTS OF SALE AND OTHER PROVISIONS AS SET FORTH IN THE MANAGEMENT STOCKHOLDERS AGREEMENT (AS DEFINED IN THE IMS HEALTH HOLDINGS, INC. 2010 EQUITY INCENTIVE PLAN). IMS HEALTH HOLDINGS, INC. ST |
|
| March 10, 2014 |
EX-10.25 Exhibit 10.25 AMENDED AND RESTATED EMPLOYMENT AGREEMENT AMENDED AND RESTATED AGREEMENT, dated as of February 12, 2014 (the “Agreement”), between IMS Health Holdings., Inc. (the “Company”), IMS Health Incorporated (“IMS”) and Ari Bousbib (the “Executive”). WHEREAS, the Company desires that the Executive continue to serve the Company as Chief Executive Officer and President of the Company a |
|
| March 10, 2014 |
EX-10.29 Exhibit 10.29 Name of Participant: Ari Bousbib IMS HEALTH HOLDINGS, INC. 2010 EQUITY INCENTIVE PLAN THIS AWARD AND ANY SECURITIES DELIVERED HEREUNDER ARE SUBJECT TO RESTRICTIONS ON VOTING AND TRANSFER AND REQUIREMENTS OF SALE AND OTHER PROVISIONS AS SET FORTH IN THE MANAGEMENT STOCKHOLDERS AGREEMENT (AS DEFINED IN THE IMS HEALTH HOLDINGS, INC. 2010 EQUITY INCENTIVE PLAN). IMS HEALTH HOLDI |
|
| February 13, 2014 |
EX-10.9 Exhibit 10.9 SECOND AMENDMENT TO THE IMS HEALTH INCORPORATED EMPLOYEE PROTECTION PLAN (as amended and restated effective September 1, 2009) Effective January 1, 2012, the IMS Health Incorporated Employee Protection Plan, as amended and restated effective September 1, 2009 and as amended by a First Amendment thereto effective January 1, 2011 (the “Plan”), is further amended as follows: The |
|
| February 13, 2014 |
EX-10.4 2 d628679dex104.htm EX-10.4 Exhibit 10.4 Execution Version SECOND AMENDED AND RESTATED CREDIT AND GUARANTY AGREEMENT dated as of October 24, 2012 among IMS HEALTH INCORPORATED, as a Borrower and a Guarantor, IMS AG, as a Borrower, IMS JAPAN K.K., as a Borrower, HEALTHCARE TECHNOLOGY INTERMEDIATE HOLDINGS, INC., as a Guarantor, CERTAIN SUBSIDIARIES OF IMS HEALTH INCORPORATED, as Guarantors, |
